Search results
FDA panel rejects MDMA-assisted therapies for PTSD despite high hopes from veterans
Fox News· 1 day agoA U.S. Food and Drug Administration (FDA) panel rejected MDMA-based treatments for post-traumatic...
The FDA Should Reject MDMA Therapy—but Not for the Reasons You Think
Slate· 23 hours agoThe FDA will officially vote Aug. 11 on whether to approve the treatment. The agency isn’t required...
Why FDA Panel Rejected MDMA Therapy—And What’s Next For Psychedelic Medicine
Forbes· 1 day agoHigh hopes that psychedelic medicines were finally on the pathway to regulation were dashed last...
With MDMA debate spreading beyond biotech, Lykos CEO tries to dispel efficacy, safety concerns
FierceBiotech· 23 hours agoA week after an FDA committee declined to support an midomafetamine (MDMA) treatment for...
MDMA Therapy for PTSD? FDA considers first psychedelic drug
KNBN Rapid City· 7 days agoFederal health advisers are weighing the first-of-a-kind approval of MDMA, the mind-altering club...
FDA advisers vote against first MDMA therapy to treat PTSD
News Channel Nebraska· 5 days agoBy Deidre McPhillips, CNN
MDMA’s Future As A Treatment For PTSD Is In Question
Inverse· 3 days agoWhile the FDA will still vote separately on MDMA, it generally follows the recommendation of its advisors, so its unlikely the novel treatment will gain approval. The drug ...
FDA Advisory Committee voted against MDMA therapy, what's next?
Task & Purpose· 7 days agoThe committee voted 10-1 against the overall benefits of MDMA in the treatment of post-traumatic...
MDMA-maker failed its FDA hearing — and its PTSD patients
The Eagle-Tribune· 6 days agoThis week, the Food and Drug Administration’s expert advisers sent a strong message that Lykos...
Trouble for ecstasy? What MDMA’s FDA setback could mean for psychedelics
NPR· 1 day agoGeneral Hospital, who presented on behalf of Lykos about the need for more PTSD treatment. Gorman acknowledges the Lykos' therapy protocol is more “open-ended ...